Analogic Corporation (NASDAQ:ALOG) insider James Patrick Ryan sold 180 shares of the stock in a transaction on Tuesday, August 15th. The shares were sold at an average price of $71.25, for a total transaction of $12,825.00. Following the transaction, the insider now owns 770 shares in the company, valued at $54,862.50. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

James Patrick Ryan also recently made the following trade(s):

  • On Monday, July 17th, James Patrick Ryan sold 180 shares of Analogic Corporation stock. The shares were sold at an average price of $69.45, for a total transaction of $12,501.00.
  • On Thursday, June 15th, James Patrick Ryan sold 180 shares of Analogic Corporation stock. The shares were sold at an average price of $67.80, for a total transaction of $12,204.00.

Analogic Corporation (NASDAQ:ALOG) traded down 0.50% on Wednesday, reaching $70.00. 61,255 shares of the company’s stock were exchanged. The stock’s market capitalization is $872.90 million. Analogic Corporation has a 12 month low of $66.00 and a 12 month high of $95.85. The firm has a 50 day moving average of $70.94 and a 200 day moving average of $73.43.

Analogic Corporation (NASDAQ:ALOG) last announced its quarterly earnings data on Tuesday, June 6th. The medical research company reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.74 by $0.05. The business had revenue of $122.16 million for the quarter, compared to the consensus estimate of $121.35 million. Analogic Corporation had a negative net margin of 7.97% and a positive return on equity of 6.75%. Analogic Corporation’s quarterly revenue was down 4.5% on a year-over-year basis. During the same quarter last year, the company posted $0.80 earnings per share. Equities analysts predict that Analogic Corporation will post $2.60 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Analogic Corporation (ALOG) Insider James Patrick Ryan Sells 180 Shares” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://www.americanbankingnews.com/2017/08/16/analogic-corporation-alog-insider-james-patrick-ryan-sells-180-shares.html.

Separately, Jefferies Group LLC assumed coverage on shares of Analogic Corporation in a research note on Wednesday, August 9th. They set a “hold” rating and a $75.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $87.00.

Several large investors have recently made changes to their positions in ALOG. Koch Industries Inc. bought a new stake in shares of Analogic Corporation during the first quarter valued at about $283,000. Alambic Investment Management L.P. increased its stake in shares of Analogic Corporation by 62.7% in the first quarter. Alambic Investment Management L.P. now owns 15,150 shares of the medical research company’s stock valued at $1,150,000 after buying an additional 5,840 shares during the last quarter. Stifel Financial Corp increased its stake in shares of Analogic Corporation by 9.8% in the first quarter. Stifel Financial Corp now owns 102,503 shares of the medical research company’s stock valued at $7,805,000 after buying an additional 9,129 shares during the last quarter. AXA bought a new stake in shares of Analogic Corporation during the first quarter valued at about $425,000. Finally, Geode Capital Management LLC increased its stake in shares of Analogic Corporation by 8.4% in the first quarter. Geode Capital Management LLC now owns 104,722 shares of the medical research company’s stock valued at $7,947,000 after buying an additional 8,092 shares during the last quarter.

About Analogic Corporation

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Insider Buying and Selling by Quarter for Analogic Corporation (NASDAQ:ALOG)

Receive News & Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related companies with MarketBeat.com's FREE daily email newsletter.